GlassScriptPhysician profile
Charity Dawn Johnson
NPI 1730522129
$6,448.05
in general payments reported to CMS, 2019-2025
46 companies · $1,187 in 2025
The $1,187 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $798 · 2021: $2,003 · 2022: $1,327 · 2023: $220 · 2024: $352 · 2025: $1,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,203.03 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $983.76 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $788.02 | 2019-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $580.35 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $337.37 | 2019-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $290.44 | 2019-2023 | Bexsero, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $289.46 | 2022-2025 | |
| Pfizer INC. | $237.92 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.60 | 2022-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $189.44 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.99 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $97.92 | 2020-2022 | |
| Axsome Therapeutics, INC. | $67.24 | 2025 | Symbravo |
| Biohaven Pharmaceutical Holding Company LTD. | $66.47 | 2022 | |
| Biogen, INC. | $65.97 | 2021-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charity Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.